TY - JOUR
T1 - Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
AU - Bhat, Krishna P.L.
AU - Balasubramaniyan, Veerakumar
AU - Vaillant, Brian
AU - Ezhilarasan, Ravesanker
AU - Hummelink, Karlijn
AU - Hollingsworth, Faith
AU - Wani, Khalida
AU - Heathcock, Lindsey
AU - James, Johanna D.
AU - Goodman, Lindsey D.
AU - Conroy, Siobhan
AU - Long, Lihong
AU - Lelic, Nina
AU - Wang, Suzhen
AU - Gumin, Joy
AU - Raj, Divya
AU - Kodama, Yoshinori
AU - Raghunathan, Aditya
AU - Olar, Adriana
AU - Joshi, Kaushal
AU - Pelloski, Christopher E.
AU - Heimberger, Amy
AU - Kim, Se Hoon
AU - Cahill, Daniel P.
AU - Rao, Ganesh
AU - DenDunnen, Wilfred F.A.
AU - Boddeke, Hendrikus W.G.M.
AU - Phillips, Heidi S.
AU - Nakano, Ichiro
AU - Lang, Frederick F.
AU - Colman, Howard
AU - Sulman, Erik P.
AU - Aldape, Kenneth
N1 - Funding Information:
We would like to acknowledge the Caroline Ross Endowment Fellowship, the American Brain Tumor Association Basic Research Fellowship, the Odyssey Special Fellowship, and the MDACC Brain Tumor SPORE Career Development grant (to K.P.L.B.); the Brain Tumor Funders’ Collaborative, the Dr. Marnie Rose Foundation, and the National Brain Tumor Society (to K.A.); the V Foundation and SPORE grant P50CA127001 from NIH/NCI (to K.A. and H.C.); the Huntsman Cancer Foundation (to H.C.); the Ben and Cathy Ivy Foundation Research Award (to F.F.L., K.A., and E.P.S.); the SPORE Animal Core grant (to F.F.L.); grant R01-CA1208113 from NIH/NCI (to A.H.); and Dutch Cancer Society grant RUG 2011-5150 (to V.B., H.W.B., and W.F.D.) for their generous support. We thank Alicia Ledoux, Bhavna Singh, and Susan Cweren for histology; Verlene Henry for animal injections; and the Flow Cytometry & Cellular Imaging Core Facility, Small Animal Imaging Facility, and the Division of Surgery Pathology Core Facility (all at MDACC supported by P30-CA016672) for technical support. We apologize for not citing some original references because of space limitations. H.S.P. is an employee and stockholder of Roche/Genentech.
PY - 2013/9/9
Y1 - 2013/9/9
N2 - Despite extensive study, few therapeutic targets have been identified for glioblastoma (GBM). Here weshow that patient-derived glioma sphere cultures (GSCs) that resemble either the proneural (PN) or mesenchymal (MES) transcriptomal subtypes differ significantly in their biological characteristics. Moreover, we found that a subset of the PN GSCs undergoes differentiation to a MES state in a TNF-α/NF-κB-dependent manner with an associated enrichment of CD44 subpopulations and radioresistant phenotypes. We present data to suggest that the tumor microenvironment cell types such as macrophages/microglia may play an integral role in this process. We further show that the MES signature, CD44 expression, and NF-κB activation correlate with poor radiation response and shorter survival in patients with GBM.
AB - Despite extensive study, few therapeutic targets have been identified for glioblastoma (GBM). Here weshow that patient-derived glioma sphere cultures (GSCs) that resemble either the proneural (PN) or mesenchymal (MES) transcriptomal subtypes differ significantly in their biological characteristics. Moreover, we found that a subset of the PN GSCs undergoes differentiation to a MES state in a TNF-α/NF-κB-dependent manner with an associated enrichment of CD44 subpopulations and radioresistant phenotypes. We present data to suggest that the tumor microenvironment cell types such as macrophages/microglia may play an integral role in this process. We further show that the MES signature, CD44 expression, and NF-κB activation correlate with poor radiation response and shorter survival in patients with GBM.
UR - http://www.scopus.com/inward/record.url?scp=84883656941&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84883656941&partnerID=8YFLogxK
U2 - 10.1016/j.ccr.2013.08.001
DO - 10.1016/j.ccr.2013.08.001
M3 - Article
C2 - 23993863
AN - SCOPUS:84883656941
SN - 1535-6108
VL - 24
SP - 331
EP - 346
JO - Cancer cell
JF - Cancer cell
IS - 3
ER -